Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
The mammalian target of rapamycin (mTOR) is an evolutionarily conserved Ser/Thr protein kinase that plays a pivotal role in multiple fundamental biological processes, including synaptic plasticity. We explored the relationship between the mTOR pathway and β-amyloid (Aβ)-induced synaptic dysfunction,...
Main Authors: | Tao Ma, Charles A Hoeffer, Estibaliz Capetillo-Zarate, Fangmin Yu, Helen Wong, Michael T Lin, Davide Tampellini, Eric Klann, Robert D Blitzer, Gunnar K Gouras |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-09-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2942840?pdf=render |
Similar Items
-
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease
by: Davide Tampellini
Published: (2010-05-01) -
Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01) -
Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer’s Disease
by: Isak Martinsson, et al.
Published: (2022-07-01) -
Dysregulation of mTOR Signaling after Brain Ischemia
by: Mario Villa-González, et al.
Published: (2022-03-01) -
Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.
by: Reisuke H Takahashi, et al.
Published: (2013-01-01)